Syneron Candela Introducing New Technologies at the 2016 AAD Annual Meeting

Syneron Medical Ltd., is launching three new products during the 2016 American Academy of Dermatology (AAD) meeting in Washington, DC. The launches include the new CO₂RE Intima system for gynecological and genitourinary indications, an ultra-short picosecond PicoWay laser wavelength, and a Profound SubQ hand piece.

• CO₂RE Intima, part of Syneron Candela's  CO₂RE platform, is launching to address a growing need in the gynecology market for women's intimate wellness. CO₂RE Intima is designed to perform gynecological and genitourinary treatments by stimulating healing responses in the vaginal and vulva areas, while also remodeling the tissue fibers in the vaginal and vulva areas. "Our launch of CO₂RE Intima provides physicians with additional options when using our CO₂RE platform, allowing us to successfully provide wellness solutions to the gynecology market.  We are very pleased with feedback from our early investigators and believe that the CO₂RE Intima will provide compelling value to patients and providers," says Shimon Eckhouse, PhD, Co-founder and Chairman of the Board, Syneron-Candela.
• The Company is launching a third, ultra-short pulse duration 785nm wavelength for PicoWay for tattoo removal, pigmentation correction, and to treat skin irregularities. The new ultra-short wavelength is the first of its kind in the aesthetic market utilizing a titanium sapphire laser for the removal of blue and green inks. The innovative PicoWay laser platform delivers ultra-short pulses of energy (e.g., 300 picoseconds at 785 nm) making treatments shorter and less painful for patients while offering the industry's shortest pulses and highest peak power. The addition of PicoWay's third wavelength completes the PicoWay laser platform, allowing for the comprehensive removal and treatment of all colors of tattoos and skin pigmentation issues.
• Profound^®, a microneedle-based radiofrequency device, is clinically proven to stimulate three important factors for percutaneous treatment of facial wrinkles: elastin, collagen, and hyaluronic acid. The company is launching a new SubQ hand piece for Profound for the treatment of adipose tissue and deeper connective tissue. With the launch of the new SubQ applicator, Profound offers real-time temperature controlled micro-needling radiofrequency device for the treatment of both shallow and deep skin at the dermal and subcutaneous layers.

"We are very pleased to be able offer such a broad array of technologically sophisticated solutions to our customers and their patients," said Amit Meridor, chief executive officer for Syneron Candela. "Our new launches represent Syneron Candela's ongoing commitment to advancing technology and providing the widest range of solutions to the aesthetic and wellness marketplace."

Visit the Syneron Candela booth (Booth #2421) at the AAD to learn more.